The story of Sildenafil presents a nuanced case for investors in the medicinal sector. While initially a tremendous success, producing vast sums, the intellectual property lapse and the subsequent entry of generic https://adult931446.get-blogging.com/42197627/viagra-and-pharma-a-risky-bet